1. Home
  2. ICCC vs RCON Comparison

ICCC vs RCON Comparison

Compare ICCC & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • RCON
  • Stock Information
  • Founded
  • ICCC 1982
  • RCON 2007
  • Country
  • ICCC United States
  • RCON China
  • Employees
  • ICCC N/A
  • RCON N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • RCON Oilfield Services/Equipment
  • Sector
  • ICCC Health Care
  • RCON Energy
  • Exchange
  • ICCC Nasdaq
  • RCON Nasdaq
  • Market Cap
  • ICCC 47.4M
  • RCON 45.3M
  • IPO Year
  • ICCC 1987
  • RCON 2009
  • Fundamental
  • Price
  • ICCC $5.20
  • RCON $1.89
  • Analyst Decision
  • ICCC
  • RCON
  • Analyst Count
  • ICCC 0
  • RCON 0
  • Target Price
  • ICCC N/A
  • RCON N/A
  • AVG Volume (30 Days)
  • ICCC 22.3K
  • RCON 11.0K
  • Earning Date
  • ICCC 05-14-2025
  • RCON 06-27-2025
  • Dividend Yield
  • ICCC N/A
  • RCON N/A
  • EPS Growth
  • ICCC N/A
  • RCON N/A
  • EPS
  • ICCC N/A
  • RCON N/A
  • Revenue
  • ICCC $26,493,169.00
  • RCON $8,996,572.00
  • Revenue This Year
  • ICCC N/A
  • RCON N/A
  • Revenue Next Year
  • ICCC N/A
  • RCON $12.17
  • P/E Ratio
  • ICCC N/A
  • RCON N/A
  • Revenue Growth
  • ICCC 51.63
  • RCON N/A
  • 52 Week Low
  • ICCC $3.34
  • RCON $1.32
  • 52 Week High
  • ICCC $5.82
  • RCON $3.70
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.84
  • RCON 55.92
  • Support Level
  • ICCC $5.01
  • RCON $1.40
  • Resistance Level
  • ICCC $5.72
  • RCON $1.91
  • Average True Range (ATR)
  • ICCC 0.18
  • RCON 0.16
  • MACD
  • ICCC -0.04
  • RCON 0.01
  • Stochastic Oscillator
  • ICCC 37.50
  • RCON 81.67

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About RCON Recon Technology Ltd.

Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.

Share on Social Networks: